AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Xbrane Biopharma AB (publ)

SEK 14.15 +$3.78 (+36.45%)
STO · 30 Oct 2026 11:59 UTC
Previous Close
SEK 13.00
Day Range
SEK 13.70SEK 15.50
Year Range
SEK 5.42SEK 20.00
Market Cap
172.27M
AVG Volume
66.72K
Trailing/Forward PE
-7.83/-
PEG ratio
0.07
Dividend Yield
-
Next Earnings Date
2027-02-19
Primary Exchange
Stockholm Stock ExchangeSE
Revenue (SEK) · TTM
0100M200M300M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBRANE.ST Revenue (SEK) by quarter, trailing twelve months
PeriodRevenue (SEK)
26 Q3127.95M
26 Q283.3M
26 Q176.44M
25 Q4152.34M
25 Q3209.16M
25 Q2265.85M
25 Q1277.95M
24 Q4198.78M
24 Q3199.77M
24 Q2191.85M
Net Income (SEK) · TTM
-600M-400M-200M0200M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBRANE.ST Net Income (SEK) by quarter, trailing twelve months
PeriodNet Income (SEK)
26 Q3-62.68M
26 Q2-75M
26 Q1106M
25 Q4127.24M
25 Q3100.53M
25 Q279.44M
25 Q1-160.65M
24 Q4-266.22M
24 Q3-370.56M
24 Q2-406.67M
Operating Income (SEK) · TTM
-400M-300M-200M-100M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBRANE.ST Operating Income (SEK) by quarter, trailing twelve months
PeriodOperating Income (SEK)
26 Q3-57.93M
26 Q2-70.91M
26 Q1-63.91M
25 Q4-25.56M
25 Q3-34.53M
25 Q2-49.17M
25 Q1-105.12M
24 Q4-222.06M
24 Q3-273.61M
24 Q2-325.91M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (SEK) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: XBRANE.ST

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 19 Feb 2027.

Xbrane Biopharma AB (publ)
XBRANE.ST
Stockpicker

Video analysis: XBRANE.ST

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: XBRANE.ST

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.